Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries

PURPOSE: Health technology assessment (HTA) coverage recommendations differ across countries for the same drugs. Unlike previous studies, this study adopts a mixed methods research design to investigate, in a systematic manner, these differences. METHODS: HTA recommendations for ten orphan drugs app...

Descripción completa

Detalles Bibliográficos
Autor principal: Nicod, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486466/
https://www.ncbi.nlm.nih.gov/pubmed/27538758
http://dx.doi.org/10.1007/s10198-016-0823-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486466/
https://www.ncbi.nlm.nih.gov/pubmed/27538758
http://dx.doi.org/10.1007/s10198-016-0823-0

Ejemplares similares